Adverse effects of stromal vascular fraction during regenerative treatment of the intervertebral disc: observations in a goat model

• Published in: European spine journal Vol. 24; no. 9; pp. 1992 - 2000
• Main Authors: Detiger, Suzanne E. L., Helder, Marco N., Smit, Theodoor H., Hoogendoorn, Roel J. W.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.09.2015; Springer Nature B.V
• Subjects: Adipose Tissue - cytology; Animals; Cell- and Tissue-Based Therapy - adverse effects; Erythrocytes; Female; Goats; Inflammation - etiology; Inflammation - pathology; Injections, Intralesional; Intervertebral Disc - pathology; Intervertebral Disc Degeneration - pathology; Intervertebral Disc Degeneration - therapy; Medicine; Medicine & Public Health; Multipotent Stem Cells - transplantation; Neovascularization, Pathologic - etiology; Neovascularization, Pathologic - pathology; Neurosurgery; Original Article; Regeneration; Regenerative Medicine; Surgical Orthopedics; Animal model; Degeneration; Stromal vascular fraction; Adipose stem cells; Intervertebral disc
• ISSN: 0940-6719; 1432-0932
• DOI: 10.1007/s00586-015-3803-7

Stromal vascular fraction (SVF), an adipose tissue-derived heterogeneous cell mixture containing, among others, multipotent adipose stromal cells (ASCs) and erythrocytes, has proved beneficial for a wide range of applications in regenerative medicine. We sought to establish intervertebral disc (IVD) regeneration by injecting SVF intradiscally during a one-step surgical procedure in an enzymatically (Chondroitinase ABC; cABC) induced goat model of disc degeneration. Unexpectedly, we observed a severe inflammatory response that has not been described before, including massive lymphocyte infiltration, neovascularisation and endplate destruction. A second study investigated two main suspects for these adverse effects: cABC and erythrocytes within SVF. The same destructive response was observed in healthy goat discs injected with SVF, thereby eliminating cABC as a cause. Density gradient removal of erythrocytes and ASCs purified by culturing did not lead to adverse effects. Following these observations, we incorporated an extra washing step in the SVF harvesting protocol. In a third study, we applied this protocol in a one-step procedure to a goat herniation model, in which no adverse responses were observed either. However, upon intradiscal injection of an identically processed SVF mixture into our goat IVD degeneration model during a fourth study, the adverse effects surprisingly occurred again. Despite our quest for the responsible agent, we eventually could not identify the mechanism through which the observed destructive responses occurred. Although we cannot exclude that the adverse effects are species-dependent or model-specific, we advertise caution with the clinical application of autologous SVF injections into the IVD until the responsible agent(s) are identified.